This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Sep 20;155(6):JC3-3.

doi: 10.7326/0003-4819-155-6-201109200-02003.

ACP Journal Club. Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation

Affiliations

PMID: 21930840
DOI: 10.7326/0003-4819-155-6-201109200-02003

Comment

ACP Journal Club. Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation

Marcel Levi. Ann Intern Med. 2011.

. 2011 Sep 20;155(6):JC3-3.

doi: 10.7326/0003-4819-155-6-201109200-02003.

Author

Affiliation

¹ Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

PMID: 21930840
DOI: 10.7326/0003-4819-155-6-201109200-02003

No abstract available

PubMed Disclaimer

Comment on

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S. Eikelboom JW, et al. Circulation. 2011 May 31;123(21):2363-72. doi: 10.1161/CIRCULATIONAHA.110.004747. Epub 2011 May 16. Circulation. 2011. PMID: 21576658 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon